Primary |
Hormone Replacement Therapy |
58.8% |
Menopausal Symptoms |
20.6% |
Menopause |
5.9% |
Postmenopause |
5.9% |
Hormone Therapy |
2.9% |
Hot Flush |
2.9% |
Insomnia |
2.9% |
|
Breast Cancer |
21.9% |
Drug Ineffective |
6.3% |
Drug Intolerance |
6.3% |
Hypersensitivity |
6.3% |
Paraesthesia |
6.3% |
Pharmaceutical Product Complaint |
6.3% |
Swelling |
6.3% |
Abdominal Distension |
3.1% |
Breast Cancer Female |
3.1% |
Dizziness |
3.1% |
Drug Hypersensitivity |
3.1% |
Influenza |
3.1% |
Menopausal Symptoms |
3.1% |
Muscle Twitching |
3.1% |
Night Sweats |
3.1% |
Ovarian Cancer |
3.1% |
Product Substitution Issue |
3.1% |
Pruritus Generalised |
3.1% |
Therapeutic Response Unexpected With Drug Substitution |
3.1% |
Urticaria |
3.1% |
|
Secondary |
Hormone Replacement Therapy |
77.3% |
Menopausal Symptoms |
6.0% |
Menopause |
3.3% |
Emotional Disorder |
2.1% |
Oestrogen Replacement Therapy |
1.9% |
Pain |
1.1% |
Muscle Spasms |
1.0% |
Myalgia |
0.9% |
Night Sweats |
0.9% |
Hormone Therapy |
0.7% |
Nausea |
0.7% |
Hypertension |
0.5% |
Thyroid Disorder |
0.5% |
Blood Pressure |
0.5% |
Depression |
0.5% |
Hypothyroidism |
0.5% |
Product Used For Unknown Indication |
0.5% |
Amnesia |
0.4% |
Antidepressant Therapy |
0.4% |
Constipation |
0.4% |
|
Breast Cancer |
35.1% |
Breast Cancer Female |
33.3% |
Breast Cancer Metastatic |
11.2% |
Weight Decreased |
4.0% |
Progesterone Receptor Assay Positive |
3.2% |
Ovarian Cancer |
2.9% |
Nausea |
2.0% |
Scleroderma |
1.4% |
Invasive Lobular Breast Carcinoma |
0.9% |
Oedema Peripheral |
0.9% |
Breast Cancer In Situ |
0.6% |
Breast Cancer Stage Iii |
0.6% |
Fatigue |
0.6% |
Muscle Spasms |
0.6% |
Ovarian Cancer Metastatic |
0.6% |
Pain |
0.6% |
Peripheral Coldness |
0.6% |
Ureteric Injury |
0.6% |
Abdominal Pain |
0.3% |
Abdominal Pain Lower |
0.3% |
|
Concomitant |
Product Used For Unknown Indication |
16.6% |
Drug Use For Unknown Indication |
9.7% |
Depression |
9.5% |
Asthma |
8.3% |
Hypertension |
7.4% |
Osteoporosis |
6.7% |
Pain |
6.3% |
Rheumatoid Arthritis |
6.0% |
Hormone Therapy |
3.6% |
Gastrooesophageal Reflux Disease |
3.0% |
Sleep Disorder |
2.7% |
Smoking Cessation Therapy |
2.7% |
Anxiety |
2.6% |
Hypothyroidism |
2.6% |
Blood Cholesterol Increased |
2.5% |
Hormone Replacement Therapy |
2.5% |
Hypersensitivity |
2.0% |
Pulmonary Arterial Hypertension |
1.9% |
Psoriatic Arthropathy |
1.8% |
Arthritis |
1.7% |
|
Weight Increased |
15.6% |
Weight Decreased |
7.3% |
Blood Glucose Increased |
6.4% |
Insomnia |
6.4% |
Sepsis |
6.4% |
Vomiting |
6.4% |
Drug Ineffective |
4.6% |
Nausea |
4.6% |
Road Traffic Accident |
4.6% |
Tremor |
4.6% |
White Blood Cell Count Increased |
4.6% |
Resorption Bone Increased |
3.7% |
Rheumatoid Arthritis |
3.7% |
Throat Tightness |
3.7% |
Urticaria |
3.7% |
Joint Swelling |
2.8% |
Throat Irritation |
2.8% |
Tongue Disorder |
2.8% |
Treatment Failure |
2.8% |
Urine Output Decreased |
2.8% |
|